8-K: Investview Amends Securities Purchase Agreement with DBR Capital, Extending Loan Availability and Reducing Interest Rates

Sentiment:

8-K Filing


Investview, Inc. amended its Securities Purchase Agreement with DBR Capital, extending the availability of loans and reducing interest rates on potential future borrowings.

Capital raiseThe amendment to the Securities Purchase Agreement allows DBR Capital to lend Investview up to an additional $7.7 million.DBR Capital has until August 31, 2025, to lend a minimum of $2.0 million.DBR Capital has until December 31, 2026, to lend the remaining balance of up to $5.7 million.The loans are convertible into Investview's common stock at a conversion price of $0.007 per share.

Summary

  • Investview, Inc. has amended its Securities Purchase Agreement with DBR Capital, LLC.
  • The amendment extends the deadline for DBR Capital to lend the company a minimum of $2.0 million until August 31, 2025, and up to $5.7 million until December 31, 2026.
  • The interest rate for the first $2 million that may be advanced by DBR Capital has been reduced from 38.5% to 18.75% per annum.
  • The interest rate for any amounts loaned in excess of $2 million has been reduced to 10% per annum from 38.5%.
  • DBR Capital's funding of additional loan amounts remains at its sole discretion.
  • The loans are convertible into Investview's common stock at a conversion price of $0.007 per share.
  • The maturity date for the notes is April 30, 2030.
  • Investview seeks to avoid additional interest charges under the current lending arrangement.
  • The company contemplates a need for expansion capital in the future.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The extension of the loan availability and reduction in interest rates are positive developments. However, the discretionary nature of the funding and the existing debt burden temper the overall sentiment.

Positives

  • The amendment reduces the interest rate on potential future borrowings, which could lower Investview's financing costs.
  • Extending the availability of loans provides Investview with continued access to capital, if needed.
  • The company seeks to avoid additional interest charges under the current lending arrangement.
  • The company contemplates a need for expansion capital in the future.

Negatives

  • DBR Capital's funding of additional loan amounts remains at its sole discretion, so Investview has no guarantee of receiving the funds.
  • The loans are secured by collateral of the Company and its subsidiaries.
  • The loans bear interest at rates between 10% and 18.75% per annum, which is still relatively high.

Risks

  • DBR Capital has no obligation to fund all or any portion of the additional loans.
  • DBR Capital may cause the Company to incur the debt and associated interest charges with one or both sets of additional loans at a time when it does not need the capital.
  • The company's access to capital depends on DBR Capital's discretion.
  • The company is subject to risks and uncertainties identified in its public reports filed with the SEC.

Future Outlook

The company contemplates a need for expansion capital in the future and seeks to avoid additional interest charges under the current lending arrangement. The funding of additional loan amounts remains at the sole discretion of DBR Capital, and the Company cannot provide any assurance as to when, or if, such amounts will be funded.

Industry Context

In the current economic climate, companies are seeking flexible financing options. This amendment provides Investview with potential access to capital while reducing the cost of borrowing, which is a common strategy in similar situations.

Comparison to Industry Standards

  • Interest rates for similar convertible debt arrangements can vary widely depending on the company's creditworthiness and the prevailing market conditions.
  • Companies like Investview, seeking growth capital, often balance the need for funding with the cost of capital, opting for structures that allow for future equity upside through conversion features.
  • The interest rate reduction is a positive sign, potentially bringing the cost of capital more in line with industry averages for similar risk profiles.

Related Party Transactions

  • The loans are from DBR Capital, LLC, an affiliate of David B. Rothrock, a Board member of Investview, Inc.

Stakeholder Impact

  • Shareholders may be impacted by the potential dilution from the conversion of the loans into common stock.
  • Employees may benefit from the company's access to capital for expansion.
  • Creditors may be impacted by the increased debt on the company's balance sheet.

Next Steps

  • DBR Capital will decide whether to fund the additional loans by the specified deadlines.
  • Investview may seek alternative financing if DBR Capital declines to proceed with the Fourth Closing and/or the Fifth Closing.
  • Investview will continue to monitor its capital needs and assess the availability of funding from DBR Capital.

Key Dates

DateDescription
2020-04-27Original Securities Purchase Agreement date.
2020-11-09Amended and Restated Securities Purchase Agreement date.
2021-03-22First Amendment date.
2021-05-27Second Amendment date.
2021-11-16Third Amendment date.
2022-08-12Fourth Amendment date.
2024-12-31Original termination date of the loan arrangement.
2025-02-28Date of the Fifth Amendment to Amended and Restated Securities Purchase Agreement.
2025-08-31Deadline for DBR Capital to lend a minimum of $2.0 million.
2026-12-31Deadline for DBR Capital to lend up to $5.7 million.
2030-04-30Maturity date of the Fourth Closing Note and Fifth Closing Note.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.